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Notch proteins are transmembrane receptors that
normally adopt a resting state poised to undergo
activating proteolysis upon ligand engagement.
Receptor quiescence is maintained by three LIN12/
Notch repeats (LNRs), which wrap around a heterodi-
merization domain (HD) divided by furin cleavage at
site S1 during maturation. Ligand binding initiates
signaling by inducing sensitivity of the HD to proteol-
ysis at the regulated S2 cleavage site. Here, we used
hydrogen exchange mass spectrometry to examine
the solution dynamics of the Notch1 negative regula-
tory region in autoinhibited states before and after S1
cleavage, in a proteolytically sensitive ‘‘on’’ state,
and in a complex with an inhibitory antibody. Conver-
sion to the ‘‘on’’ state leads to accelerated deutera-
tion in the S2 region and in nearby secondary
structural elements within the HD. In contrast,
complexation with the inhibitory antibody retards
deuteration around the S2 site. Together, these
studies reveal how S2 site exposure is promoted by
receptor activation and suppressed by inhibitory
antibodies.
INTRODUCTION
Notch signaling is an ancient cell-cell communication system
that regulates embryonic and fetal development as well as adult
tissue homeostasis (Bray, 2006; Kopan and Ilagan, 2009). The
four human Notch receptors are large, single-pass transmem-
brane proteins that share a similar modular organization, with
a series of EGF repeats that bind ligands, a negative regulatory
region (NRR), and an intracellular effector domain that follows
a single transmembrane segment (Figure 1A). The receptors
are normally synthesized as precursor proteins, which are typi-
cally cleaved during transport to the cell surface (at a site called
S1) by a furin-like protease (Logeat et al., 1998).546 Structure 19, 546–554, April 13, 2011 ª2011 Elsevier Ltd All righNotch receptors are poised to undergo activating proteolysis
upon binding to transmembrane ligands on neighboring cells.
The activation switch of the receptor lies within the NRR (Kopan
et al., 1996; Sanchez-Irizarry et al., 2004), which includes a series
of three Lin12/Notch repeats (LNRs) and a heterodimerization
domain (HD) that becomes divided upon cleavage at S1 (Logeat
et al., 1998). The NRR maintains proteolytic resistance in the
absence of ligands by burying a proteolytic site called S2, which
is situated near the C-terminal end of the HD domain (Gordon
et al., 2007, 2009a, 2009b) (Figure 1B). In a process that remains
poorly understood, ligand binding then renders S2 sensitive to
cleavage by ADAM-family metalloproteases (Brou et al., 2000;
Mumm et al., 2000). The truncated receptor thus generated is
subsequently processed by the intramembrane protease called
gamma secretase to liberate the Notch intracellular domain
(ICN), which travels to the nucleus and assembles into a tran-
scriptional activation complex to regulate target gene transcrip-
tion (for a review, see Kopan and Ilagan, 2009).
Proper regulation of Notch activity is crucial, as mutations that
increase or decrease Notch signal strength can produce devel-
opmental defects or diseases such as cancer. The frequent
occurrence of activating point mutations within the Notch1
NRR in T cell lymphoblastic leukemia/lymphoma, for example,
further highlights the consequences of evenmodestly destabiliz-
ing this regulatory switch to tip the balance in favor of proteolytic
sensitivity (Malecki et al., 2006; Weng et al., 2004).
Here, we sought to explore the fundamental issue of protease
sensitivity by using hydrogen exchange mass spectrometry
(HX MS) (Wales and Engen, 2006) to examine the conformation
and dynamics of various states of the Notch1 NRR, focusing
on the kinetic accessibility of the S2 site. The data show that
the hydrophobic core of the Notch1 HD domain exchanges
more slowly than the LNR repeats, and that slow exchange of
the HD core is unaffected by S1 cleavage. Interactions between
the LNR repeats and the HD shield residues in this interdomain
interface from exchange, and relaxation of the long-range inter-
face between the LNRs and the HD allows more deuterium to
exchange into the region of the S2 site. Conversely, an anti-
Notch1 inhibitory antibody, which contacts a discontinuous
epitope encompassing residues from the first LNR domain and
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Figure 1. Domain Organization and Overview of the Notch1 NRR
Structure
(A) Domain organization of Notch1. The extracellular portion of the receptor
consists of 36 EGF-like repeats responsible for ligand binding (blue), and the
negative regulatory region (NRR, boxed) that maintains proteolytic resistance
in the absence of ligands. The NRR encompasses three LIN12/Notch repeats
(LNR-A, LNR-B, and LNR-C, colored in different shades of red), and the het-
erodimerization domain (HD, green), divided at S1 by a furin-like protease
during maturation. Ligand binding to the extracellular portion of Notch triggers
metalloprotease cleavage at site S2. The resulting truncated transmembrane
subunit of the receptor is a substrate for cleavage at S3 by gamma-secretase,
which releases the intracellular part of Notch (ICN, blue) from the membrane.
(B) Ribbon diagram of the Notch1 NRR in its autoinhibited conformation
(PDB ID code 3IO8). The three LNR modules are shown in different shades of
pink, and the HD domain is in green. Disulfide bonds are orange, and the three
calcium ions coordinated by the LNR modules are purple. Key secondary
structural elements and the S1 and S2 cleavage sites are also indicated.
See also Figure S1.
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Figure 2. HX MS of the Notch1 NRR in the ‘‘Off’’ State
(A) Extent of deuteration of peptides from the Notch1 NRR. The relative
percent deuteration is colored based on a sliding scale from yellow (<10%
incorporation) to deep red (>60% incorporation). Portions of the protein for
which it was not possible to acquire exchange information are colored gray.
(B) HX MS results comparing exchange of precursor and S1 cleaved forms of
the Notch1 NRR. There were no detectable differences in the rates of peptide
deuteration between the two proteins (see Figure S3 for exchange curves). An
absolute difference in mass of less than 0.5 Da is reported as ‘‘no change.’’
See also Figures S2 and S3, Table S1, and Movie S1.
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Insights into Notch Activation from HX-MSto a reduced amount of deuteration. Together, these studies
provide new insights into the mechanism underlying Notch auto-
inhibition, receptor activation, and the basis for allosteric modu-
lation of Notch signals by inhibitory antibodies.
RESULTS
Dynamics of the Wild-Type NRR from Human Notch1
Wefirst investigated the dynamics of the intact Notch1 NRR in its
autoinhibited conformation by HX MS. This approach, which
reports on the combined effects of hydrogen bonding and
solvent accessibility of the backbone amides of the protein, is
particularly informative when a conformational state that is not
amenable to crystallography is compared to a different confor-
mational state for which there is a high-resolution structure.
Intact protein is labeled with deuterium for various amounts ofStructure 19,time under physiological conditions. After quenching, the protein
is digested into small peptide fragments and the amount of
deuterium in each peptide measured with mass spectrometry
(see Figure S1 available online). With such data, it is possible
to assign dynamic properties to specific structural elements of
the protein because regions that aremore exposed and dynamic
undergo rapid deuteration whereas regions that are more stable
and less dynamic are deuterated more slowly (Wales and Engen,
2006). Importantly, it is also then possible to identify regions of
conformational change when data for two conformational states
are compared. The peptides analyzed in comparative analysis
studies are listed in Table S1 and mapped onto the protein
sequence in Figure S2.
Analysis of the deuteration of the wild-type Notch1 NRR in its
unprocessed form (prior to S1 cleavage) shows that the hydro-
phobic interior of the HD domain is most resistant to deuteration546–554, April 13, 2011 ª2011 Elsevier Ltd All rights reserved 547
Figure 3. EDTA Treatment Induces Notch1 Proteolytic Sensitivity
U2OS cells transiently transfected with the indicated Notch1 variants
(wt, DEGF, or DEGFDLNR) were treated with buffer containing either CaCl2
(2.5 mM) or EDTA (5 mM). Firefly luciferase reporter gene activity was
measured relative to renilla luciferase as a control. All measurements were
done in triplicate. Error bars represent standard deviation.
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Insights into Notch Activation from HX-MS(Figure 2A; Movie S1). The most highly protected secondary
structural elements in the protein include the C-terminal part of
the core helix (acore), and the central beta strand (bcore) of the
HD domain immediately following the S1 cleavage loop.
Both of these regions exchanged fewer than 15% of their back-
bone amide protons even after four hours of deuterium labeling.
The resistance of these secondary structural elements to
deuteration is indicative of their relative stability in the autoinhi-
bited state. These secondary structural elements coincide with
regions of the protein frequentlymutated in human T cell lympho-
blastic leukemia/lymphoma (Weng et al., 2004), further under-
scoring their importance in maintaining the structural integrity
of the NRR.
By comparison, the three LNR modules and the N-terminal
end of the first helix of the HD domain, which together comprise
the periphery of the structure, exhibit much more rapid deuter-
ation than the hydrophobic core of the HD domain. The
dynamics of helix three (a3) and strand five, which is the b strand
containing the S2 cleavage site (Figure 1B), are more chal-
lenging to assess, because the major peptide reporting on these
regions also includes the loop that connects them. The
hydrogen exchange data show that this peptide (encompassing
the S2 site) exhibits partial protection from exchange at the
initial time point, and incorporates additional deuterium over
time. This observation suggests that the masking of the S2
site is not absolute in the autoinhibited state, and that long-
range engagement of the LNRs with the regions surrounding
the S2 site is more dynamic than the protein interior, which
incorporates little additional deuterium over time. Finally,
peptides mapping to the loop linking LNR-B and LNR-C
(BC loop) and the unstructured linker spanning the S1 site (S1
loop) show rapid deuteration (Figure S3) that remains constant
throughout the time course of the experiment, implying a high
degree of solvent exposure and a lack of stable hydrogen
bonds. These results are in agreement with previous NMR and
X-ray studies (PDB 3ETO and 3I08) pointing to the intrinsic
flexibility of both the BC and S1 loops.
Comparison of the Dynamics of the Notch1 NRR
with and without furin Cleavage
One of the leading models for ligand-induced activation of Notch
receptors postulates that ligand engagement of S1-cleaved
receptors triggers subunit dissociation, thereby exposing the
S2 site to metalloproteases (Nichols et al., 2007). However, the
hydrophobic interior of the Notch1 NRR, which includes the acore
and bcore regions straddling the S1 cleavage site, is not rapidly
deuterated, indicating that it is protected from exchange and
substantially less dynamic than the region surrounding the S2
site. Opening of the protein to expose the S2 site would therefore
appear to be kinetically favored over subunit dissociation.
To determine directly whether or not S1 cleavage changes the
conformation of the hydrophobic core or otherwise alters the
dynamics of the Notch1 NRR, we investigated the effect of furin
cleavage on the hydrogen exchange behavior of the protein (for
experimental data, see Figure S3A). The data show that the
deuterium exchange properties of the intact and furin-cleaved,
heterodimeric forms of the Notch1 NRR are virtually indistin-
guishable (Figure 2B). Most importantly, the exchange patterns
of the acore, bcore, and S2-site regions remain unaltered, indi-548 Structure 19, 546–554, April 13, 2011 ª2011 Elsevier Ltd All righcating that the hydrophobic core is still more highly protected
than the S2 site even after cleavage at S1.
EDTA Treatment of the Notch1 NRR as a Model
for an Activated Conformation
Like the type-Amodules found in proteins of the low-density lipo-
protein receptor family (Blacklow and Kim, 1996; Fass et al.,
1997), the LNRmodules of the Notch NRR rely on three disulfide
bonds and calcium ion coordination by a conserved acidic motif
to maintain their structural integrity (Aster et al., 1999; Vardar
et al., 2003). This observation suggests that chelation of the
bound calcium ions will detach the LNR modules from the HD
domain and release the autoinhibition imposed by the long-
range interface between these domains.
Consistent with this idea, previous studies have established
that EDTA treatment activates Notch signaling in cells, and
promotes shedding of the Notch ectodomain (Krejci and Bray,
2007; Rand et al., 2000). EDTA treatment of truncated receptors
lacking the EGF repeats but retaining the NRR also promotes
ectodomain shedding (Rand et al., 2000). To determine directly
whether or not the activating effect of chelator treatment is
intrinsic to the NRR, we tested whether EDTA treatment results
in the activation of a truncated receptor in which the NRR has
been retained but all of the EGF repeats have been deleted.
The results (Figure 3) show that treatment of either full-length
Notch1 or the truncated receptor with EDTA induces a 5-fold
increase in luciferase reporter gene transcription. Moreover,
further truncation of the receptor to remove both the EGF and
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Figure 4. Comparison of HXMSPatterns for
the Notch1 NRR in ‘‘Off’’ and ‘‘On’’ States
(A) Time course of exchange, comparing deuter-
ation of the Notch1 NRR in closed and open
(EDTA-treated) states. The ribbon diagram of the
Notch1 NRR is colored according to the effect of
EDTA treatment. Regions exhibiting faster
deuteration in the presence of EDTA (with an
absolute difference in mass of at least 0.5 Da at
some point during the exchange experiment) are
colored red, and regions with no detectable
change in the deuteration rate (an absolute differ-
ence in mass of less than 0.5 Da at some point
during the exchange experiment) are green. Gray
regions correspond to segments for which no
peptide mapping data are available.
(B and C) Semilogarithmic plots showing the
relative deuterium level of two different regions
(see Figure S3B for all other peptides) of the
Notch1 NRR in closed and open states. Data
acquired from two independent experiments are
shown to highlight the reproducibility of the measurements. (B) encompasses the site of S2 cleavage and (C) corresponds to a section of the core helix in the
hydrophobic core of the HD domain.
See also Figures S2 and S3, Table S1, and Movie S2.
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Insights into Notch Activation from HX-MSunaffected by EDTA treatment. Together, these studies confirm
that the induction of signaling by EDTA is intrinsic to the NRR of
human Notch1.
In the leading model for Notch activation, detachment of the
LNR modules from the HD domain is proposed to occur in
response to ligand-induced mechanical force (e.g., Kopan and
Ilagan, 2009; Nichols et al., 2007). Here, we used a chemical
approach to model the activated state of the Notch1 NRR by
using EDTA to disengage the LNRmodules from the HD domain.
Thus, we monitored the Notch1 NRR by HX MS after chelator
treatment to probe the dynamics of the protein in this form of
the ‘‘open’’ state, comparing the pattern of exchange to that of
the native, autoinhibited protein (for data, see Figure S3B).
When the exchange properties of the LNR modules in their
calcium-loaded and calcium-free state were compared, more
rapid deuteration was observed for all three LNR repeats in their
calcium-free state after EDTA treatment (Figure 4; Movie S2).
This observation likely reflects the relaxation of structure result-
ing from removal of the bound calcium ion from each repeat
(Figure 4A). More surprisingly, HD regions at the interdomain
interface with the LNR modules, including peptides spanning
the metalloprotease-cleavage site S2 (residues 1711–1721,
Figure 4B) and a portion of the helix that precedes it (residues
1694–1702), also exhibited more rapid deuteration after EDTA
treatment, as did the C-terminal end of acore (Figure 4C). When
the S1-cleaved form of the Notch1 NRR was also probed by
HX-MS, the differences in exchange patterns between native
and EDTA-treated states were largely preserved (Figure 5; for
data, see Figure S3C). Together, these studies reveal that
hydrogen exchange at the site of metalloprotease cleavage is
inhibited due to the stabilizing influence of the long-range inter-
face between the LNR modules and the HD domain, explaining
how the long-range interface disfavors access of metallopro-
teases to S2 in the autoinhibited state. In addition, the data
also show that calcium coordination by the LNR repeats plays
an essential role in stabilizing the interface responsible for main-
taining autoinhibition.Structure 19,Molecular Basis for Anti-Notch1 NRR
Antibody - Mediated Inhibition
Allosteric antibodies that inhibit Notch signaling by binding to the
NRR have now been raised against Notch1 (Aste-Amezaga et al.,
2010; Wu et al., 2010), Notch2 (Wu et al., 2010), and Notch3
(Li et al., 2008). The epitopes for the anti-Notch3 antibody and
for one of the anti-Notch1 antibodies have been mapped, and
the X-ray structure of one of the anti-Notch1 antibodies has
been solved in complex with the Notch1 NRR. In both of these
cases, the contact interface between the antibody and the
NRR includes residues from both the LNR andHD domains, sug-
gesting that the antibodies clamp the receptor in the off state by
bridging the two domains.
Here, we examined the interaction between the humanNotch1
NRR and a different anti-NRR antagonistic antibody, WC629,
which has been shown to specifically target the NRR of Notch1
and no other Notch receptors (Aste-Amezaga et al., 2010). We
identified the binding epitope for the WC629 antibody using
a combination of HX MS and site-directed mutagenesis.
We first compared the exchange behavior of the Notch1 NRR
in the presence and absence of antibody WC629 (for data, see
Figure S3D). Binding of WC629 decreased deuterium incorpora-
tion into NRR peptides derived from the loop connecting LNR-B
to LNR-C (BC loop), a region within the HD domain immediately
preceding and including the S2 site (S2 loop), and a region from
LNR-A (Figure 6A).
To determine how residues from these three regions contribute
to antibody binding, we analyzed the recovery of complexes
between WC629 and either wild-type or mutated Notch1-NRR
‘‘minireceptors’’ in immunoprecipitation assays. The minirecep-
tors contain the three LNR modules and the complete HD
domain, with an added N-terminal FLAG tag and a C-terminal
HA-epitope tag to facilitate immunoprecipitation (Sanchez-Iri-
zarry et al., 2004). The dual tags also enable assessment of S1
cleavage and subunit association of the minireceptors as surro-
gate markers of protein structural integrity. The wild-type minire-
ceptor and all of the mutants tested (Figure S5) undergo S1546–554, April 13, 2011 ª2011 Elsevier Ltd All rights reserved 549
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Figure 5. HX-MS Relative Difference Plots
for Unprocessed N1-NRR and S1 Cleaved
N1-NRR, Comparing Closed and EDTA-
Treated States
The differences in deuterium incorporation
between the EDTA treated protein and the native
protein are plotted for deuterium exchange time
points of 10 s (blue bars), 1 min (red bars), 10 min
(green bars), and 4 hr (purple bars). The data
shown are for peptides common to both experi-
ments, ordered from N to C terminus (top to
bottom). See also Figures S2 and S3 and Table S1.
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Insights into Notch Activation from HX-MSprocessing and the subunits remain associated after processing,
as judged by recovery of the FLAG-tagged subunit following
immunoprecipitation (IP) with anti-HA. To examine WC629
binding, we attempted to immunoprecipitate complexes
between the different minireceptor proteins and WC629 with
anti-HA. The IP data revealed that substitution of the BC loop
with homologous residues of Notch2 or with alanine at six posi-
tionsdid not detectably interferewithWC629binding. In contrast,
substitution of the native sequences of the S2 loop or the LNR-A
region with the Notch2 sequences or with alanine at exposed
positions abrogated WC629 binding (Figure 6B).
To identify key residues that contributed energetically to
WC629 binding, we focused on the two residues of the S2
loop that are most solvent exposed: N1714 and K1718. We
made three additional alanine-substituted minireceptors:
N1714A/K1718A, N1714A alone and K1718A. IP studies showed
that neither N1714A/K1718A nor N1714A immunoprecipitated
WC629, whereas K1718A did, but with qualitatively less recovery
than the wild-type Notch1 NRR (Figure 6C). Based on these550 Structure 19, 546–554, April 13, 2011 ª2011 Elsevier Ltd All rights reservedstudies, we conclude that N1714 of the
S2 loop is a key energetic contributor to
WC629 binding by the Notch1 NRR.
DISCUSSION
A central key to understanding the mech-
anism of Notch activation lies in eluci-
dating how the NRR of Notch receptors
controls access of metalloprotesases to
the S2 site in response to ligand binding.
Here, we have applied HX MS to study
the intrinsic dynamics and conforma-
tional changes of the human Notch1
NRR in five distinct biochemical states
to gain insight into Notch activation and
its inhibition by allosteric antibodies that
bind to the NRR.
As the reference state for these studies,
we chose to use the uncleaved precursor
form of the Notch1 NRR, folded into its
autoinhibited, metalloprotease-resistant
conformation. The most highly protected
region of the Notch1 NRR is the hydro-
phobic interior of the HD domain, with
the beta strand immediately followingthe S1-cleavage site exhibiting the greatest degree of protection
against exchange. When deuterium exchange of the precursor
protein is compared with that of the S1-cleaved molecule,
there are no detectable differences, indicating no significant
conformational change upon S1 cleavage. This result is consis-
tent with previous evidence that the S1 cleavage site of Notch1
lies within a long, unstructured loop (Gordon et al., 2009b).
To model the Notch ‘‘on’’ state of the receptor, we released
autoinhibition by incubation of the Notch1 NRR with the divalent
metal ion chelator EDTA. Because the LNR modules rely on
calcium coordination for their structural integrity, this treatment
relaxes the structural integrity of the LNR modules (Aster et al.,
1999; Vardar et al., 2003), disengages the LNR domain from
the HD, and promotes proteolytic activation of Notch in cells
(Figure 3) (Rand et al., 2000). Whether the ‘‘end state’’ of the
HD domain after EDTA-induced activation faithfully mimics the
‘‘end state’’ of the HD after physiologic activation of Notch
receptors is, of course, an open question. If ligand-induced
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Figure 6. The WC629 Inhibitory Antibody
Bridges the LNR and HD Domains and
Retards Deuteration of the S2 Region
(A) Ribbon diagram of the Notch1 NRR, colored
according to the effect of antibody binding.
Regions exhibiting slower deuteration in the
presence of the antibody (with an absolute differ-
ence in mass of at least 0.5 Da) are colored blue,
and regions with no detectable change in the
deuteration rate (an absolute difference in mass of
less than 0.5 Da) are green. Gray regions corre-
spond to segments for which no HX MS data were
obtained.
(B) Epitope fine mapping. The indicated wild-type
and mutated Notch1 NRR minireceptors, which
are divided at S1 into two subunits during matu-
ration, were tagged with FLAG and HA epitopes at
their N and C termini, respectively, and complexes
were precipitated with an anti-HA antibody. The
top panel shows coprecipitation of the FLAG- and
HA-tagged subunits for all mutants tested, veri-
fying S1 cleavage and stable subunit association.
The bottom panel shows coimmunoprecipitation
of the WC629 inhibitory antibody with the mini-
receptor. The bound WC629 antibody was de-
tected with a goat anti-human-HRP antibody
conjugate. BCL: BC-loop; S2L: S2 loop; SWN2:
Notch2 sequence swap; CM: conditioned media;
B: beads. The sequences of the mutations tested
are listed in Figure S5.
(C) Point mutagenesis of N1714 and K1718 of the
S2 loop. Left panel shows coprecipitation of the
FLAG- and HA-tagged subunits and right panel
shows coimmunoprecipitation of the WC629
inhibitory antibody with the minireceptor. Copre-
cipitation experiments were carried out as above
in (B).
See also Figures S2–S4 and Table S1.
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Insights into Notch Activation from HX-MSaway from the HD domain, as many researchers have proposed
(for a review, see Kopan and Ilagan, 2009), it seems reasonable
to posit that the use of EDTA to induce detachment of the LNRs
from the HD chemically (as opposed to mechanically) should
lead to a similar endpoint in terms of the structure and dynamics
of the HD domain.
Although the peptide coverage of the LNRs is incomplete,
comparison of the exchange into the autoinhibited and EDTA-
treated NRRs suggests that the degree of protection of the
LNR modules follows the order LNR-A < LNR-B < LNR-C. The
kinetics of exchange of the region flanking the S2 site parallels
the exchange behavior of the LNR-B repeat, and chelator treat-
ment appears to promote relaxation of helix three, which imme-Structure 19, 546–554, April 13, 2011diately precedes and packs against the
terminal beta strand that houses the S2
site. This finding suggests that detaching
the LNR-B repeat from the HD domain is
needed to relax the structural elements
of the HD domain that encompass the
S2 site to allow metalloprotease access,
and provides an explanation for the
observation that both the LNR-A and
LNR-B repeats must be deleted to resultin substantial ligand-independent signaling activity of the Notch1
NRR (Gordon et al., 2007).
The hydrophobic interior of the HD domain, including the core
beta hairpin that straddles the S1-cleavage site, is the region of
the protein most highly protected against exchange. The core
beta hairpin does not exhibit greater exchange after EDTA treat-
ment, a finding that contrasts with the increased rate of
exchange that occurs at the S2 site in response to EDTA treat-
ment. These data argue against current models for activation
invoking ligand-induced dissociation of S1-cleaved Notch
receptors prior to metalloprotease cleavage, because (1) the
core of the HD domain is intrinsicially more highly protected
against exchange than the S2 site and (2) exchange of thisª2011 Elsevier Ltd All rights reserved 551
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Insights into Notch Activation from HX-MScore is not enhanced under conditions that promote metallopro-
tease cleavage.
It is important to emphasize that the studies reported here do
not distinguish between different models for ligand-induced acti-
vation (e.g., mechanical force, allosteric switch, etc.). Although
EDTA treatment relaxes thestructureof theLNRmodules,making
it possible to probe the intrinsic dynamics of the HD in its ‘‘un-
masked’’ state for comparison to the autoinhibited (masked)
state, it is a nonphysiologic activating stimulus, and thus our
experiments do not address whether or not the LNR domains
are peeled off mechanically from the site during physiologic acti-
vation by ligands. (It is, however, worth noting that ligands might
apply enough force to peel the LNR modules away from the HD
without actually dissociating the subunits before S2 cleavage
takesplace, for example, if the kineticsofmetalloproteaseaccess
to and cleavage of the HD domain at S2 occurs more rapidly than
does the increase in force required to dissociate the subunits).
The work reported here also lays the groundwork for future
experiments to study the activation dynamics in pathogenic
Notch signaling, whichmay exhibit subtle differences from phys-
iologic or EDTA-induced signaling. All known activating point
mutations of Notch1 found in T cell acute lymphoblastic
leukemia/lymphoma (T-ALL) lead to increased ligand-indepen-
dent signaling. The most common mutations associated with
T-ALL lie within the hydrophobic core of the HD and typically
cause thermodynamic destabilization of the NRR (Malecki
et al., 2006; Weng et al., 2004). It would be informative to deter-
mine whether these mutations increase the exchange rate of the
hydrophobic core of the HD to the point at which the activation
mechanism becomes dissociation driven, as anticipated for at
least three of the T-ALL associated mutations that promote
subunit dissociation in vitro (Malecki et al., 2006).
These studies also examined how the binding of a potent allo-
steric inhibitory antibody affects the exchange kinetics of Notch1
NRR to shed light on the mechanism of antibody inhibition.
Mapping of the epitope by combining hydrogen exchange data
with mutational studies clearly identified residues in LNR-A and
in the loop preceding the S2-cleavage site as key contributors
to the energetics of antibody binding. The exchange studies
also established that a peptide including the S2 site is more pro-
tected against exchange upon antibody treatment, providing
direct evidence that kinetic access to the metalloprotease site
is reduced when antibody is bound.
Over the past several years, Notch receptors have emerged as
attractive therapeutic targets in cancer as well as in other
diseases (Miele et al., 2006; Rizzo et al., 2008). The HX MS
approach developed here can be used to evaluate candidate
molecules that emerge from screens selecting for compounds
designed to inhibit Notch signaling either by stabilizing the
NRR in its autoinhibited conformation or by directly masking
the S2 site. Such compounds would be invaluable not only as
therapeutic agents but also as experimental tools to study the
consequences of signaling by individual Notch receptors.EXPERIMENTAL PROCEDURES
Protein Expression and Purification
The human Notch1 NRR (residues E1446 to Q1733; GenBank ID 148833507)
was subcloned into the pET15b vector containing an N-terminal hexahistidine552 Structure 19, 546–554, April 13, 2011 ª2011 Elsevier Ltd All rightag followed by a TEV cleavage site. Thus, the NRR contains an additional
glycine at its N terminus after release of the histidine tag by TEV cleavage.
The Notch1 NRR-WT protein was prepared essentially as previously described
(Gordon et al., 2009b). In brief, the protein was produced recombinantly in
RosettaII(DE3)pLysS bacteria and recovered from the insoluble fraction using
5M urea. The protein was affinity-purified on a nickel column, eluted with imid-
azole and treated with TEV protease to remove the His6 tag. The protein was
refolded in vitro by dialysis in a redox buffer containing 5 mM cysteine and
1 mM cystine. Refolding progress was monitored by HPLC. The refolded
protein was further purified by anion exchange chromatography. To prepare
the S1-cleaved form of the Notch1 NRR, purified Notch1 NRR-WT (0.5 mg)
was subjected to in vitro S1 cleavage by treating with recombinant furin
(40 units; New England Biolabs) overnight in a buffer containing 10 mM Tris
[pH 8], 10 mM NaCl, and 10 mM CaCl2 (Gordon et al., 2009b). Cleavage was
determined to have gone to completion when the Notch1 NRR-WT precursor
band on SDS-PAGE was no longer detectable. The furin-cleaved NRR was
purified by size exclusion chromatography in 25mMTris buffer (pH 8), contain-
ing 150 mM NaCl and 10 mM CaCl2. To prepare Notch1 NRR-EDTA, purified
Notch1 NRR-WT (5 mg/ml) was treated with 20 mM EDTA for 2 hr at room
temperature. The EDTA-treated NRR was directly used in the HX MS experi-
ment without further purification.Hydrogen Exchange-Mass Spectrometry Experiments
Experiments were performed as reported previously (Iacob et al., 2009), with
the following details tailored specifically to the Notch system. A stock solution
(75 mM) of Notch1 NRR-WT, Notch1 NRR-S1 or Notch1 NRR-EDTA (75 pmol)
was prepared in 25 mM Tris buffer (pH 8), 150 mM NaCl, and 10 mM CaCl2,
H2O. For the HX MS experiment monitoring exchange of Notch1 NRR-WT in
complex with WC629, we first incubated 75 pmol of Notch1 NRR-WT with
84 pmol of WC629 for 3 hr in the same buffer. Deuterium exchange was initi-
ated by diluting the stock solution 15-fold with 25 mM Tris (p2H 8), 150 mM
NaCl, and 10 mM CaCl2, in
2H2O at 21
C. At each deuterium exchange time
point (10 s, 1 min, 10 min, 1 hr, and 4 hr) labeling was quenched by adding
an equal volume of quench buffer (200 mM citrate buffer, 0.5 M TCEP, 4M
guanidine HCl, H2O [pH 2.3]) and dropping the temperature rapidly to 0
C.
After 10 min in the quench buffer at 0C, a step that was required to reduce
the disulphide bonds and allow for efficient pepsin digestion, each sample
was injected into a custom Waters nanoACQUITY platform equipped with
an 2.1 3 50 mm immobilized pepsin column for digestion and UPLC system
for separation of resulting peptic peptides (system described in detail in Wales
et al., 2008). The peptides were separated with a gradient of 8%–40% aceto-
nitrile in 6 min (both mobile phases contained 0.05% formic acid [pH 2.6]) and
directed into a Waters QTof Premier mass spectrometer with conventional
electrospray ionization source. The mass spectrometer settings were: ESI+
mode; capillary 3500 V; cone 35 V; desolvation and source temperatures
were 175C and 80C, respectively; nitrogen desolvation gas flow of 600
liters/hr; mass acquisition range of 50–2000 m/z; scan rate of 0.2 scans/
second; instrument always collecting data in MSE mode. Continuous lock
mass correction was accomplished with infusion of a peptide standard every
30 s for amass accuracy of 3–5 ppm. The data were analyzed with HX-Express
(Weis et al., 2006) and other custom macros. Each experiment was performed
in duplicate. Only peptides detected in both the tests and reference conditions
were used in comparative analyses (Figure S2). The threshold for detecting
differences between samples was set well outside the error of making each
measurement, as determined by duplicate measurements (see replicate
curves in Figures 4B and 4C and Figure S3B) and prior analyses of many
proteins with this experimental setup. An absolute difference in mass of
0.5 Dawas used as a threshold for the comparisons. Any point in the deuterium
exchange curves with the difference in mass of less than 0.5 Da was reported
as ‘‘no change.’’ Throughout the manuscript, data that are plotted on the same
graph were obtained using identical experimental conditions, thus negating
the need for back-exchange correction for comparison purposes (Wales and
Engen, 2006). Much more caution must be used comparing data not on the
same graph because in order to compare such data on an absolute deuterium
basis, a back-exchange correction which takes into account experimental
variation from day to daymust be applied. As we wished to determine the rela-
tive difference between protein states (for example, as shown in Figure 4 andts reserved
Structure
Insights into Notch Activation from HX-MSFigure S3), no such back-exchange correction was made. All mass spectra
indicated that all peptic peptides underwent exchange with EX2 kinetics.
Reporter Assays
Triplicate cultures were plated at 13 105 U2OS cells per well of a 6-well dish in
cell culture medium. After 24 hr, cells in each well were cotransfected with
750 ng of TP1-luciferase reporter plasmid, 15 ng of an internal control Renilla
luciferase reporter plasmid (pRL-TK), and with 60 ng of various human Notch1
constructs in pcDNA3 (Invitrogen) or with vector alone using Lipofectamine
2000 (Invitrogen). After 24 hr, the transfected cells were treated with either
2.5 mM CaCl2 or 5 mM EDTA for 10 min, and then resupplied with cell culture
medium for an additional 6 hr. Cells were then harvested, and firefly and renilla
luciferase activities were quantitated in cell lysates by using a dual luciferase
assay (Promega).
Immunoprecipitation
Using Lipofectamine 2000, 293T cells in a 10 cm dish were transiently trans-
fected with 3 mg of empty pcDNA3 plasmid or with pcDNA3 plasmids encoding
various human Notch1 NRR minireceptors. To enable detection, these minire-
ceptors were fused to FLAG and HA tags at the N and C termini, respectively
(Sanchez-Irizarry et al., 2004). As a result of furin cleavage during expression,
the resulting polypeptides are secreted as heterodimers, with the N-terminal
subunits containing a FLAG tag, and the C-terminal subunits bearing an
HA tag. Forty-eight hours after transfection, conditioned media were collected
andmixed with the antibodyWC629 for 3 hr. Themixtures were incubatedwith
anti-HA beads (Covance) overnight at 4C. After washing the beads three
times, the bound proteins on the beads were analyzed by SDS-PAGE and
western blot. The upper part of the western blots, which contained the
FLAG-tagged portion of the NRR, was stained with rabbit anti-FLAG antibody
and then goat anti-rabbit antibody conjugated to horseradish peroxidase
(HRP). The lower part of the blots, which contained the HA-tagged portion of
the NRR, was stained with mouse anti-HA and goat anti-mouse-HRP
antibodies. Western blots to detect WC629 binding were stained using goat
anti-human-HRP andWestPico chemiluminescent substrate (Pierce-Thermo).
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